{"id":"https://openalex.org/W4392409696","doi":"https://doi.org/10.1136/bmjgh-2023-edc.253","title":"PA-631 The immunopathogenic mechanisms of severe cutaneous adverse drug reactions to first line anti-tuberculosis drugs","display_name":"PA-631 The immunopathogenic mechanisms of severe cutaneous adverse drug reactions to first line anti-tuberculosis drugs","publication_year":2023,"publication_date":"2023-12-01","ids":{"openalex":"https://openalex.org/W4392409696","doi":"https://doi.org/10.1136/bmjgh-2023-edc.253"},"language":"en","primary_location":{"id":"doi:10.1136/bmjgh-2023-edc.253","doi":"https://doi.org/10.1136/bmjgh-2023-edc.253","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjgh-2023-edc.253","pdf_url":"https://gh.bmj.com/content/bmjgh/8/Suppl_10/A103.3.full.pdf","source":{"id":"https://openalex.org/S2764928273","display_name":"BMJ Global Health","issn_l":"2059-7908","issn":["2059-7908"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abstracts of Poster and e-Poster Presentations","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://gh.bmj.com/content/bmjgh/8/Suppl_10/A103.3.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028219887","display_name":"Phuti Choshi","orcid":"https://orcid.org/0000-0001-8860-9635","observed_orcids":["https://orcid.org/0000-0001-8860-9635"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Phuti Chosi","raw_affiliation_strings":["University of Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057215968","display_name":"Sarah Pedretti","orcid":"https://orcid.org/0000-0003-4005-8453","observed_orcids":["https://orcid.org/0000-0003-4005-8453"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Sarah Pedretti","raw_affiliation_strings":["University of Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031509709","display_name":"Rannakoe J. Lehloenya","orcid":"https://orcid.org/0000-0002-1281-1789","observed_orcids":["https://orcid.org/0000-0002-1281-1789"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Rannakoe Lehloenya","raw_affiliation_strings":["University of Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080985934","display_name":"Elizabeth Jane Phillips","orcid":"https://orcid.org/0000-0002-7623-3383","observed_orcids":["https://orcid.org/0000-0002-7623-3383"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Phillips","raw_affiliation_strings":["Vanderbilt University Medical Center, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009308092","display_name":"Jonny Peter","orcid":"https://orcid.org/0000-0002-2658-0723","observed_orcids":["https://orcid.org/0000-0002-2658-0723"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Jonathan Peter","raw_affiliation_strings":["University of Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"GBP","value_usd":3679},"apc_paid":{"value":3000,"currency":"GBP","value_usd":3679},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A103.3","last_page":"A104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/severe-cutaneous-adverse-reactions","display_name":"severe cutaneous adverse reactions","score":0.9419999718666077},{"id":"https://openalex.org/keywords/first-line-antituberculosis-drugs","display_name":"first-line antituberculosis drugs","score":0.8679999709129333},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.8889999985694885},{"id":"https://openalex.org/keywords/drug-reaction-with-eosinophilia-and-systemic-symptoms","display_name":"DRESS syndrome","score":0.8669999837875366},{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.9039999842643738},{"id":"https://openalex.org/keywords/toxic-epidermal-necrolysis","display_name":"toxic epidermal necrolysis","score":0.9470000267028809},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.453000009059906},{"id":"https://openalex.org/keywords/cd8-t-cell-exhaustion","display_name":"CD8+ T cell exhaustion","score":0.8529999852180481},{"id":"https://openalex.org/keywords/tcr-repertoire","display_name":"T cell receptor repertoire","score":0.722000002861023},{"id":"https://openalex.org/keywords/ifn-gamma-elispot","display_name":"IFN-gamma ELISPOT","score":0.7269999980926514},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.7170000076293945},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.8137811422348022},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.7185238003730774},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6839703321456909},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6545974016189575},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5127862095832825},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.49591025710105896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.465476930141449},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4569355547428131},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.4284391403198242},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.4110642373561859},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37800562381744385},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.2405884563922882},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/bmjgh-2023-edc.253","doi":"https://doi.org/10.1136/bmjgh-2023-edc.253","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjgh-2023-edc.253","pdf_url":"https://gh.bmj.com/content/bmjgh/8/Suppl_10/A103.3.full.pdf","source":{"id":"https://openalex.org/S2764928273","display_name":"BMJ Global Health","issn_l":"2059-7908","issn":["2059-7908"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abstracts of Poster and e-Poster Presentations","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/bmjgh-2023-edc.253","doi":"https://doi.org/10.1136/bmjgh-2023-edc.253","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjgh-2023-edc.253","pdf_url":"https://gh.bmj.com/content/bmjgh/8/Suppl_10/A103.3.full.pdf","source":{"id":"https://openalex.org/S2764928273","display_name":"BMJ Global Health","issn_l":"2059-7908","issn":["2059-7908"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abstracts of Poster and e-Poster Presentations","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4392409696.pdf","grobid_xml":"https://content.openalex.org/works/W4392409696.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7155596420","https://openalex.org/W2466833946","https://openalex.org/W4399427728","https://openalex.org/W2477673314","https://openalex.org/W3110088614","https://openalex.org/W4377564608","https://openalex.org/W7066423523","https://openalex.org/W7217595874","https://openalex.org/W2677418649","https://openalex.org/W2897185535"],"abstract_inverted_index":{"Background":[0],"First-line":[1],"anti-tuberculosis":[2],"drugs":[3],"(FLTD)":[4],"are":[5,27],"the":[6,193,200,225],"commonest":[7],"cause":[8],"of":[9,23,124,137,184,230,261],"severe":[10],"immune-mediated":[11],"adverse":[12],"drug":[13],"reactions,":[14],"including":[15,234],"SJS/TEN":[16,51],"and":[17,32,52,57,60,70,107,115,132,160,167,207,217,249,293],"DRESS":[18,53,87],"in":[19,35,130,142,215,232,288],"PLHV.":[20],"The":[21,164],"mechanisms":[22],"these":[24,113,138,150],"life-threatening":[25],"reactions":[26],"poorly":[28],"understood,":[29],"making":[30],"diagnosis":[31],"treatment":[33],"challenging":[34],"patients":[36,266],"who":[37],"can":[38],"ill-afford":[39],"suboptimal":[40],"treatment.":[41],"Methods":[42],"We":[43,148,251],"aimed":[44],"to":[45,74,112,237,241,285,298],"identify":[46,238],"genetic":[47],"markers":[48],"for":[49,93,99,175],"FLTD-induced":[50],"through":[54],"HLA,":[55],"ERAP":[56],"KIR":[58],"typing,":[59],"used":[61],"an":[62],"integrated":[63],"single-cell":[64,108],"approach":[65],"involving:":[66],"i)":[67],"CyTOF2":[68],"(n=8),":[69],"ii)":[71],"ScRNA-seq":[72],"(n=3)":[73],"characterise":[75],"peripheral":[76],"blood":[77],"immune":[78,120],"cells":[79,129,141],"activated":[80],"by":[81],"offending":[82],"drug.":[83],"Results":[84],"Rifampicin":[85],"(RIF)-associated":[86],"was":[88,95,110],"commonest.":[89],"IFN-gamma":[90,239],"ELISPOT,":[91],"optimised":[92,235],"FLTDs,":[94],"most":[96],"sensitive":[97],"(75%)":[98],"RIF-DRESS.":[100,250],"RIF-DRESS/SJS/TEN(ELISPOT+)":[101],"cases":[102,114,131,143],"were":[103,213],"associated":[104],"with":[105,151,157,178,243],"HLA-B*44:03,":[106],"work":[109,229,295],"restricted":[111],"matched":[116],"controls.":[117,133,290],"HIV-related":[118,262],"chronic":[119],"activation":[121],"drove":[122],"expansion":[123],"exhausted":[125,256],"(CD57+PD-1+TIGIT+)":[126],"CD8+":[127,139,155,180,257,270],"T":[128,140,271],"However,":[134],"a":[135,171,244],"subpopulation":[136],"expressed":[144],"co-stimulation":[145],"(CD28+CD27+)":[146],"markers.":[147],"confirmed":[149],"ScRNA-seq,":[152],"as":[153,203],"KLRG1lowCX3CR1high":[154],"T-cells":[156,211,240,282],"RIF-specific":[158],"proliferative":[159,206],"cytotoxic":[161,208,269],"capabilities":[162],"(IFNGhiTNFhiGNLYhiGZMBhiPerforinhi).":[163],"V-J":[165],"junction":[166],"CDR3\u03b1\u03b2":[168],"analysis":[169,183],"showed":[170],"unique":[172],"TCR":[173],"repertoire":[174],"each":[176],"case,":[177],"predominantly":[179],"oligoclonality.":[181],"GLIPH2":[182],"TCR\u03b2":[185],"sequences":[186],"found":[187],"eight":[188],"common":[189],"T-cell":[190,258,303],"groups":[191],"across":[192],"three":[194],"cases.":[195],"Differential":[196],"gene":[197],"expression":[198],"identified":[199],"SQVP":[201],"TCR-motif":[202],"having":[204],"RIF-induced":[205],"profiles.":[209],"Regulatory":[210],"(CD127lowCD25hiCCR4hi)":[212],"higher":[214],"controls":[216],"produced":[218],"more":[219],"TGF-beta.":[220],"Conclusion":[221],"This":[222],"study":[223],"is":[224,296],"first":[226],"detailed":[227],"immunophenotyping":[228],"RIF-DRESS":[231,265],"PLHV;":[233],"ELISPOT":[236],"FLTD,":[242],"strong":[245],"association":[246],"between":[247],"HLA-B*44:03":[248],"propose":[252],"that,":[253],"despite":[254],"expanded,":[255],"populations":[259],"characteristic":[260],"advanced":[263],"immunosuppression,":[264],"have":[267],"drug-specific":[268],"cells,":[272],"potentially":[273],"sharing":[274],"low-frequency":[275],"TCR-motifs":[276],"like":[277],"SQVP.":[278],"Increased":[279],"functional":[280],"regulatory":[281],"may":[283],"contribute":[284],"maintaining":[286],"tolerance":[287],"HLAB*44:03+":[289],"Future":[291],"site-of-disease":[292],"in-vitro":[294],"required":[297],"better":[299],"define":[300],"proposed":[301],"pathogenic":[302],"populations.":[304]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2024-03-05T00:00:00"}